文献速递肺外科

疑似肺癌未经病理确诊的肺叶切除术

Lobectomy for Suspected Lung Cancer Without Prior Diagnosis.
PubMed 文献 · Ann Thorac Surg · 2023-06-02

该研究基于胸外科医师学会数据库回顾性分析2006至2019年间2651例疑似或确诊原发性肺部恶性肿瘤的肺叶或双肺叶切除术。术前活检确诊占51.6%,临床疑似占48.4%;在临床疑似病例中,54.4%未获诊断即行肺叶切除术,最终病理证实肺癌占90%,非恶性疾病占10%。结论认为在未确诊情况下行肺叶切除术常见,但术前组织学确认更佳。

要点

  • 未确诊即行肺叶切除术者最终病理非恶性疾病占10%(70/698)。
  • 诊断性肺叶切除术手术死亡率为1.0%(7/698),全队列为0.94%(25/2651)。

核心结论

  • 疑似肺癌未经诊断即行肺叶切除术常见,代表实践差异,非恶性疾病切除率低(诊断性切除中10%,全部肺叶切除术中2.6%)。
  • 术前组织学确认更佳,尤其在手术风险增加时。
  • 对于经过仔细选择的患者和病变,诊断性肺叶切除术是可接受的。

研究设计与样本

  • 回顾性综述,利用胸外科医师学会数据库的参与者样本,连续纳入疑似或确诊原发性肺部恶性肿瘤行肺叶或双肺叶切除术的病例。
  • 共纳入2006年至2019年间2617例患者中的2651例肺叶切除术。
  • 比较活检标本确诊肺癌与临床疑似病例,采用单变量和多变量分析识别与未获活检确诊即行肺叶切除术相关的变量。

主要发现

  • 术前活检确诊肺癌占51.6%(1368/2651),临床疑似占48.4%(1283/2651)。
  • 临床疑似病例中,585例(45.6%)术中活检证实肺癌后行肺叶切除术,698例(54.4%)未获诊断即行肺叶切除术。
  • 未获诊断即行肺叶切除术者最终病理证实肺癌占90%(628/698),非恶性疾病占10%(70/698)。
  • 非肿瘤性病理包括肉芽肿(30/70,43%)、肺炎(12/70,17%)、支气管扩张(7/70,10%)及其他病变(21/70,30%)。
  • 手术死亡率全队列为0.94%(25/2651),仅诊断性肺叶切除术为1.0%(7/698)。

临床怎么用

  • 作者认为术前组织学确认更佳,尤其在手术风险增加时。
  • 作者认为对于经过仔细选择的患者和病变,诊断性肺叶切除术是可接受的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We describe use, patients, and outcome of diagnostic lobectomy for suspected lung cancer without pathologic confirmation. METHODS: A retrospective review of consecutive lobectomy or bilobectomy for suspected or confirmed primary pulmonary malignancy was conducted using our participant's sample of The Society of Thoracic Surgeons database. Surgeons performed lobectomy based on clinical diagnosis or confirmation on a biopsy specimen. Lung cancer confirmed by biopsy specimen was compared with cases clinically suspected. Univariate and multivariate analyses identified variables associated with lobectomy without biopsy specimen confirmation. RESULTS: Among 2651 lobectomies performed between 2006 and 2019 in 2617 patients, lung cancer was confirmed by preoperative biopsy specimen in 51.6% (1368 of 2651) or was clinically suspected before the operation in 48.4% (1283 of 2651). The intraoperative biopsy specimen in 585 of 1283 cases (45.6%) proved lung cancer before lobectomy, whereas lobectomy proceeded in 698 cases (54.4%) without a diagnosis. Final pathology proved lung cancer in 90% (628 of 698) without a diagnosis before lobectomy and nonmalignant disease in 10% (70 of 698). Nonneoplastic pathology included granulomas (30 of 70 [43%]), pneumonia (12 of 70 [17%]), bronchiectasis (7 of 70 [10%]), and other lesions (21 of 70 [30%]). Operative mortality was 0.94% (25 of 2651) for the cohort and 1.0% (7 of 698) for diagnostic lobectomy only. Multivariate analysis identified patient age, type of lobectomy (right middle lobe), and the intermediate study tercile as associated with diagnostic lobectomy. CONCLUSIONS: Lobectomy for suspected lung cancer without diagnosis is common, represents practice variation, and infrequently (10% diagnostic, 2.6% all lobectomies) removes nonmalignant disease. Tissue confirmation before lobectomy is preferred, particularly when operative risk is increased. Diagnostic lobectomy is acceptable in carefully selected patients and lesions.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Onwugbufor MT, Soni ML, Predina JD, et al. Lobectomy for Suspected Lung Cancer Without Prior Diagnosis. Ann Thorac Surg. 2023. PMID: 37271441. doi:10.1016/j.athoracsur.2023.05.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。